SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-16-013614
Filing Date
2016-12-13
Accepted
2016-12-13 07:00:13
Documents
10
Period of Report
2016-12-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_121316.htm 8-K 10620
2 PRESS RELEASE exh_991.htm EX-99.1 20408
3 PRESENTATION MATERIALS exh_992.htm EX-99.2 9793
4 exh992_1.jpg GRAPHIC 82277
5 exh992_2.jpg GRAPHIC 243215
6 exh992_3.jpg GRAPHIC 100301
7 exh992_4.jpg GRAPHIC 116737
8 exh992_5.jpg GRAPHIC 103419
9 exh992_6.jpg GRAPHIC 113267
10 exh992_7.jpg GRAPHIC 81580
  Complete submission text file 0001171843-16-013614.txt   1200319
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 162047578
SIC: 2836 Biological Products, (No Diagnostic Substances)